loading page

Severe tumor lysis syndrome during the induction therapy for the treatment of blastic plasmacytoid dendritic cell neoplasm from myelodysplastic/myeloproliferative neoplasms
  • +6
  • Ken Sagou,
  • Makoto Ito,
  • Yuma Kawamura,
  • Shun Ukai,
  • Miyo Goto,
  • Nobuaki Fukushima,
  • Kazutaka Ozeki,
  • Ryuichi Fukuyama,
  • Akio Kohno
Ken Sagou
Konan Kosei Hospital
Author Profile
Makoto Ito
Konan Kosei Hospital
Author Profile
Yuma Kawamura
Konan Kosei Hospital
Author Profile
Shun Ukai
Konan Kosei Hospital
Author Profile
Miyo Goto
Konan Kosei Hospital
Author Profile
Nobuaki Fukushima
Konan Kosei Hospital
Author Profile
Kazutaka Ozeki
Konan Kosei Hospital
Author Profile
Ryuichi Fukuyama
Konan Kosei Hospital
Author Profile
Akio Kohno
Konan Kosei Hospital
Author Profile

Abstract

Blastic plasmacytoid dendritic cell neoplasm is a rare disease with difficulty in diagnosis, and clinical courses of patients with BPDCN vary widely. We report a case of a 63-year-old man with BPDCN showing severe tumor lysis syndrome (TLS). BPDCN with high tumor burden should be carefully considered to prevent TLS.

Peer review status:ACCEPTED

01 May 2020Submitted to Clinical Case Reports
06 May 2020Submission Checks Completed
06 May 2020Assigned to Editor
13 May 2020Reviewer(s) Assigned
25 Aug 2020Review(s) Completed, Editorial Evaluation Pending
05 Sep 20201st Revision Received
08 Sep 2020Submission Checks Completed
08 Sep 2020Assigned to Editor
08 Sep 2020Review(s) Completed, Editorial Evaluation Pending
08 Sep 2020Reviewer(s) Assigned
19 Sep 2020Editorial Decision: Accept